Biotechnology | Disease | FDA | Therapeutics
FDA Approves Two Oral Therapies to Treat Gonorrhea
On Dec. 12, 2025, the U.S. Food and Drug Administration (FDA) announced it has approved two new oral…
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | Non-Profit Research | Oncology | Rare Disease | Therapeutics
CIRM approves over $160M to support preclinical and clinical research, advances education opportunities and access to clinical trials
On Dec. 11, 2025, the California Institute for Regenerative Medicine (CIRM) governing board approved funding of over $160…
WHO expert group’s new analysis reaffirms there is no link between vaccines and autism
On Dec. 11, 2025, a new analysis from a World Health Organization(WHO) global expert committee on vaccine safety…
Genomic Maps Untangle the Complex Roots of Disease
On Dec. 10, 2025, researchers from Gladstone Institutes and Stanford University announced they have leveraged a comprehensive method…
Biotechnology | CRISPR | Disease | FDA | Genomics | Stem Cell | Therapeutics
FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease
On Dec. 8, 2025, the U.S. Food and Drug Administration (FDA) approved two milestone treatments, Casgevy and Lyfgenia,…
Biotechnology | CDC | Diagnostics | Disease | FDA | Vaccine | Women's Health
US vaccine advisers say not all babies need a hepatitis B shot at birth
On Dec. 5, 2025, a federal vaccine advisory committee voted on Friday to end the longstanding recommendation that…
Biotechnology | CDC | Disease | FDA | Vaccine
The West Coast Health Alliance, CDPH, and Leading National Medical Organizations Continue to Recommend Hepatitis B Vaccination for Newborns
On Dec. 5, 2025, the West Coast Health Alliance (WCHA) announced that it strongly supports that hepatitis B…
AI fails to reliably detect pediatric pneumonia on X-ray
Dec. 4, 2025, new research from the University of Washington (UW) underscores risks of using publicly available large-language…
Noninvasive imaging could replace finger pricks for people with diabetes
On Dec. 3, 2025, Massachusetts Institute of Technology (MIT) engineers announced they can accurately measure blood glucose by…
Disease | Infectious Disease | Measles | Medicine | Non-Profit Research | Therapeutics | Vaccine | WHO | Women's Health
Nearly one in five child deaths linked to growth failure
On Dec. 2, 2025, findings in the latest Global Burden of Disease 2023 study published in The Lancet…
Biotechnology | Cardiology | Disease | Therapeutics | WHO
WHO issues global guideline on the use of GLP-1 medicines in treating obesity
On Dec. 1, 2025, the World Health Organization (WHO) has released its first guideline on the use of…
Anonymous donor gifts $50M to help University of Washington train ‘unsung heroes’ of healthcare
On Dec. 1, 2025, in an unusual act of philanthropy, an anonymous donor has committed more than $50…
Artificial Intelligence | Biology | Diagnostics | Disease | Medicine | Pharmaceutical | Therapeutics
MIT scientists debut a generative AI model that could create molecules addressing hard-to-treat diseases
On Nov. 25, 2025, a team of Massachusetts Institute of Technology scientists reported that AI model BoltzGen generates…
Disease | Environmental | USDA
Pathogens spread by high-flying wind-borne mosquitoes
On Nov. 25, 2025, recent studies published in PNAS have revealed that many mosquito species regularly engage in…
Doctors still outperform AI in clinical reasoning, study shows
On Nov. 24, 2025, a study published in the New England Journal of Medicine show that a test…
WHO Reports Diphtheria outbreak in African Region
On Nov. 21, 2025, the World Health Organization (WHO) reported that from 1 January to 2 November 2025,…
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | FDA | Genomics | HIV | Infectious Disease | Influenza | Nanotechnology | Neurology | NIH | Oncology | Organ Transplant | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
Halted NIH Clinical Trials List Reveals Slashed Treatments for Cancer, COVID and Minority Health
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
Type 1 diabetes cured in mice with gentle blood stem-cell and pancreatic islet transplant
On Nov. 18, 2025, Stanford Medicine researchers reported that a combination blood stem cell and pancreatic islet cell…
Biotechnology | Disease | FDA | Therapeutics
Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
On Nov. 17, 2025, Sandoz announced that TYRUKO® (natalizumab-sztn) is available to patients in the US. Developed by…
CRISPR breakthrough reverses chemotherapy resistance in lung cancer
On Nov. 17, 2025,In a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute have…
New DNA Test to Track Leishmaniasis Infections
On Nov. 12, 2025, a study led by the Hebrew University of Jerusalem, and the Laboratory of Entomology…
Existing evidence does not clearly link paracetamol use during pregnancy with autism or ADHD in children
On Nov. 10, 2025, a study led by the University of Liverpool reported that existing evidence does not…
Despite global decrease, Chagas disease is rising in non-endemic regions
On Nov. 6, 2025, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School…
WHO publishes new global research agenda to strengthen paediatric clinical trials
On Nov. 6, 2025, the World Health Organization (WHO) released a technical report, The future of paediatric clinical trials…
Steady glucose-monitor use helps blood-sugar control
On Nov. 5, 2025, a large study of adults with type 2 diabetes showed that those who consistently…
Successful bone regeneration using stem cells derived from fatty tissue
On Nov. 5, 2025, an Osaka Metropolitan University team has used stem cells extracted from adipose, the body’s…
MIT researchers invent new human brain model to enable disease research, drug discovery
On Nov. 5, 2025, MIT researchers announced they have developed a new 3D human brain tissue platform, the…
Biotechnology | Disease | FDA | Therapeutics
FDA approves menin inhibitor for patients with acute leukemia with NPM1 mutation, backed by Dana-Farber science
On Nov. 4, 2025, the U.S. Food and Drug Administration (FDA) approved revumenib, a first-in-class oral menin inhibitor,…
Wildfire smoke tied to higher risk of preterm birth
On Nov. 4, 2025, a team of scientists led by the University of Washington announced findings published this…
United Therapeutics Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease
On Nov. 3, 2025, United Therapeutics, a public benefit corporation, announced the first clinical xenotransplantation in its EXPAND…